We know about the complexities the pharmaceutical industry faces when meeting government policies on prescription drugs, and that is why Grup Maculart works through continuous improvement policies. Our mission is to keep our customers satisfied and to offer them innovative solutions.
We have all certifications ready available for our customers in case they may want to check out on them +Info.
Grup Maculart follows a service policy, and an innovation and investment strategy that allows us to respond to the requirements of the industry and pursue a day-by-day adjustment to the changes in the regulations; it is thanks to this that our customers trust us.
Among the last improvements in our equipment we can count on the acquisition of the IMPIKA Compact 24X24 High Speed / High Quality by Xerox. It has been specifically designed to meet our needs and our customers’ quality requirements. It caters for a greater swiftness in the manufacturing process and a more secure tracking of all middle processes in the leaflets manufacturing: printing and folding, as well as shrink-fitting. Moreover, this equipment reinforces our environmental care commitment as the technique allows for the use of water-based ink, which considerably reduces the emission of volatile organically compounds and guarantees a sustainable printing process.
Delivery deadlines met
*Endorsed by our clients in the pharmaceutical industry
Our Clients continuously assess us*
*An internal survey is carried out within the ISO 2014 framework following these criteria: quality, delivery, customer service and pricing